Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
MONTELUKAST ARENA 4 mg
Leukotriene receptor antagonist, indicated in the treatment of asthma and allergic rhinitis
Active Substance (INN)
MONTELUKASTUM SODIUM
Packaging
1,2,4 blisters x 7 chewable tablets 1,2,3,5 blisters x 10 chewable tablets
Adverse Reaction Reporting
To report an adverse reaction, please contact us using the email address below and provide all relevant information.
informatii.medicale@arenagroup.roRead the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.